ANTIDIABETOGENIC CALCIUM-PEPTIDE COMPOSITION

摘要

The invention relates to the use of a calcium-peptide composition obtained from at least one calcium salt, at least one caseinophosphopeptide (CPP), and/or at least one glycomacropeptide (GMP) for producing an agent for preventing and/or treating type II diabetes. Administering said composition makes it possible to significantly suppress the onset of type II diabetes (antidiabetogenic effect).